|
|
aTyr Pharma Inc
NASDAQ •
Healthcare •
Biotechnology •
Quote as of 10/23/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization16.19 mln
Float93.76 mln
Earnings Date11/05/2026
Pre-Tax Margin
-32,006%
Severely loss-making
Key Fundamentals
EPS-0.61
ROE-92.33
RPS0.00
ROIC-424
ROA-67.29
EBITDA, mln-59.23
EV / EBITDA0.27
EV / EBIT0.27
Revenue, mln0.19
Quote Details
Last
0.1651
Change
-0.0049 (-2.88%)
Open
0.1703
Volume
1,215,959
Turnover
200,755
Average Volume
2,259,132
Financial Ratios
Pre-Tax Profit Margin-32,006
Leverage Ratio1.43
Current Ratio5.12
Price / Book0.61
Price / Tangible Book0.61
Debt / Equity0.23
Price / Sales153
Financial Strength
Altman Z-Score-13.79
Piotroski F-Score
4
/ 9
Short Ratio1.72
Short % of Float13.19
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-5.11% |
17
/ 100
 |
| 1 Month |
-51.1% |
4
/ 100
 |
| 2 Months |
-66.06% |
4
/ 100
|
| 6 Months |
-78.97% |
4
/ 100
|
| 1 Year |
-82.91% |
8
/ 100
 |
|
| |
